Annual ROE
-34.78%
-0.12%-0.35%
31 December 2023
Summary:
Verve Therapeutics annual return on equity is currently -34.78%, with the most recent change of -0.12% (-0.35%) on 31 December 2023. During the last 3 years, it has fallen by -106.29% (-148.64%). VERV annual ROE is now -135.24% below its all-time high of 98.69%, reached on 31 December 2019.VERV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-36.52%
-0.23%-0.63%
30 September 2024
Summary:
Verve Therapeutics quarterly return on equity is currently -36.52%, with the most recent change of -0.23% (-0.63%) on 30 September 2024. Over the past year, it has increased by +1.52% (+4.00%). VERV quarterly ROE is now -148.02% below its all-time high of 76.05%, reached on 31 March 2021.VERV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.3% | +4.0% |
3 y3 years | -148.6% | +47.3% |
5 y5 years | - | - |
VERV ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -148.6% | at low | -0.6% | +47.3% |
5 y | 5 years | -135.2% | at low | -148.0% | +67.3% |
alltime | all time | -135.2% | at low | -148.0% | +67.3% |
Verve Therapeutics ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -36.52%(+0.6%) |
June 2024 | - | -36.29%(-3.5%) |
Mar 2024 | - | -37.60%(-2.8%) |
Dec 2023 | -34.78%(+0.3%) | -38.69%(+1.7%) |
Sept 2023 | - | -38.04%(-6.2%) |
June 2023 | - | -40.56%(+7.8%) |
Mar 2023 | - | -37.63%(+3.2%) |
Dec 2022 | -34.66% | -36.46%(-5.3%) |
Sept 2022 | - | -38.52%(+5.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | -36.55%(-1.5%) |
Mar 2022 | - | -37.11%(-17.4%) |
Dec 2021 | -33.67%(-147.1%) | -44.92%(-35.1%) |
Sept 2021 | - | -69.24%(-38.1%) |
June 2021 | - | -111.77%(-247.0%) |
Mar 2021 | - | 76.05%(+6.3%) |
Dec 2020 | 71.51%(-27.5%) | - |
Dec 2020 | - | 71.51% |
Dec 2019 | 98.69% | - |
FAQ
- What is Verve Therapeutics annual return on equity?
- What is the all time high annual ROE for Verve Therapeutics?
- What is Verve Therapeutics annual ROE year-on-year change?
- What is Verve Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Verve Therapeutics?
- What is Verve Therapeutics quarterly ROE year-on-year change?
What is Verve Therapeutics annual return on equity?
The current annual ROE of VERV is -34.78%
What is the all time high annual ROE for Verve Therapeutics?
Verve Therapeutics all-time high annual return on equity is 98.69%
What is Verve Therapeutics annual ROE year-on-year change?
Over the past year, VERV annual return on equity has changed by -0.12% (-0.35%)
What is Verve Therapeutics quarterly return on equity?
The current quarterly ROE of VERV is -36.52%
What is the all time high quarterly ROE for Verve Therapeutics?
Verve Therapeutics all-time high quarterly return on equity is 76.05%
What is Verve Therapeutics quarterly ROE year-on-year change?
Over the past year, VERV quarterly return on equity has changed by +1.52% (+4.00%)